Time-dependent Nephrotoxicity Associated with Daily Administration of Cisplatin in Mice
- 1 December 2000
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 52 (12) , 1499-1504
- https://doi.org/10.1211/0022357001777711
Abstract
The chronopharmacokinetics and chronopharmacodynamics of cisplatin were studied in a mouse model to reveal the mechanisms of dosing time-dependent nephrotoxicity induced by daily administration. Chronotoxicity was tested by daily intraperitoneal injections of cisplatin (6 mg kg−1) for 5 days at four time points (0400, 1000, 1600 and 2200h) in BALB/c mice (n = 6 in each group). After following the changes in body weight, serum concentrations of blood urea nitrogen (BUN) and creatinine obtained on day 6 were compared. In conclusion, chrononephrotoxicity induced by daily cisplatin administration does not only depend on cisplatin accumulation, but might also depend on kidney sensitivity to diurnal variations in inflammatory reaction without direct cisplatin toxicity. The results showed diurnal variations in cisplatin toxicity, with the 0400 and 1600h time points the best and the worst, respectively. We then measured platinum concentrations in blood, liver and kidney and compared the results of the 0400 and 1600 h groups (n = 4 in each group). Kidney sensitivity to cisplatin alone, lipopolysaccharide (LPS) alone, cisplatin with LPS and saline (control) were also measured using a tissue culture system (a measurement system of interleukin-6 (IL-6) production) between the 0400 and the 1600h groups (n = 4 in each group). These results showed no significant difference in platinum accumulation between the two groups. IL-6 production was higher in the 1600h group than in the 0400h group after saline injection alone (P < 0.05). Cisplatin treatment alone did not increase IL-6 production. However, IL-6 levels were markedly augmented by cisplatin with LPS.Keywords
This publication has 13 references indexed in Scilit:
- Effects of Dosing Time and Schedule on Cisplatin-Induced Nephrotoxicity in RatsJournal of Pharmacy and Pharmacology, 2000
- Phase II Study of the Activity and Tolerability of a Combined Regimen of High-Dose Epirubicin and Cisplatin in Stage IIIb and IV Non-Small Cell Lung CancerTumori Journal, 1998
- Patients with ovarian carcinoma upstaged to Stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patientsCancer, 1998
- Diurnal Uptake of Circulating Interleukin-1α by Brain, Spinal Cord, Testis and MuscleNeuroimmunomodulation, 1998
- Circadian rhythm of leucocytes and lymphocyte subsets and its possible correlation with the function of the autonomic nervous systemClinical and Experimental Immunology, 1997
- Cadmium-Induced Renal Damage and Proinflammatory Cytokines: Possible Role of IL-6 in Tubular Epithelial Cell RegenerationToxicology and Applied Pharmacology, 1995
- Role of Tumor Necrosis Factor-α in Cadmium-Induced HepatotoxicityToxicology and Applied Pharmacology, 1995
- Cisplatin nephrotocity: Role of filtration and tubular transport of cisplatin in isolated perfused kidneysToxicology, 1987
- Circadian Timing of Cancer ChemotherapyScience, 1985
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979